Literature DB >> 530525

Stimulating effect of angiotensin II on the spontaneous release of newly synthetized [3H]dopamine in rat striatal slices.

G Simonnet, M F Giorguieff-Chesselet.   

Abstract

Angiotensin II (A II) (10(-6) M, 10(-5) M, 5 . 10(-5) M) stimulated the spontaneous release of [3H]dopamine (DA) continuously synthetized from [3H]tyrosine in striatal slices of the rat. The A II-evoked release of [3H]-DA was prevented when slices were superfused with a calcium-free medium containing EGTA 5 . 10(-4) M. It was also suppressed in the presence of the potent antagonist Sar1-Ile8-angiotensin.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 530525     DOI： 10.1016/0304-3940(79)96105-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN： 0304-3940            Impact factor:   3.046


  10 in total

1.  The novel nonapeptide acein targets angiotensin converting enzyme in the brain and induces dopamine release.

Authors:  Jérémie Neasta; Charlène Valmalle; Anne-Claire Coyne; Eric Carnazzi; Gilles Subra; Jean-Claude Galleyrand; Didier Gagne; Céline M'Kadmi; Nicole Bernad; Gilbert Bergé; Sonia Cantel; Philippe Marin; Jacky Marie; Jean-Louis Banères; Marie-Lou Kemel; Valérie Daugé; Karine Puget; Jean Martinez
Journal:  Br J Pharmacol       Date:  2016-03-08       Impact factor: 8.739

2.  Brain Angiotensin II AT1 receptors are involved in the acute and long-term amphetamine-induced neurocognitive alterations.

Authors:  Natalia Andrea Marchese; Emilce Artur de laVillarmois; Osvaldo Martin Basmadjian; Mariela Fernanda Perez; Gustavo Baiardi; Claudia Bregonzio
Journal:  Psychopharmacology (Berl)       Date:  2015-11-28       Impact factor: 4.530

Review 3.  Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.

Authors:  John W Wright; Brent J Yamamoto; Joseph W Harding
Journal:  Prog Neurobiol       Date:  2007-11-19       Impact factor: 11.685

4.  Effect of angiotensin II and vasopressin on acquisition and extinction of conditioned avoidance in rats.

Authors:  D Baranowska; J J Braszko; K Wiśniewski
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

5.  Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo.

Authors:  D C Brown; L J Steward; J Ge; N M Barnes
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

6.  Fluid intake, what's dopamine got to do with it?

Authors:  Elizabeth G Mietlicki-Baase; Jessica Santollo; Derek Daniels
Journal:  Physiol Behav       Date:  2021-04-07

7.  Loss of angiotensin II receptor expression in dopamine neurons in Parkinson's disease correlates with pathological progression and is accompanied by increases in Nox4- and 8-OH guanosine-related nucleic acid oxidation and caspase-3 activation.

Authors:  W Michael Zawada; Robert E Mrak; JoAnn Biedermann; Quinton D Palmer; Stephen M Gentleman; Orwa Aboud; W Sue T Griffin
Journal:  Acta Neuropathol Commun       Date:  2015-02-03       Impact factor: 7.801

8.  Angiotensin-II Modulates GABAergic Neurotransmission in the Mouse Substantia Nigra.

Authors:  Maibam R Singh; Jozsef Vigh; Gregory C Amberg
Journal:  eNeuro       Date:  2021-04-20

9.  Angiotensin II AT₁ receptors are involved in neuronal activation induced by amphetamine in a two-injection protocol.

Authors:  Maria Constanza Paz; Natalia Andrea Marchese; Liliana M Cancela; Claudia Bregonzio
Journal:  Biomed Res Int       Date:  2013-09-08       Impact factor: 3.411

10.  The intracellular angiotensin system buffers deleterious effects of the extracellular paracrine system.

Authors:  Begoña Villar-Cheda; Maria A Costa-Besada; Rita Valenzuela; Emma Perez-Costas; Miguel Melendez-Ferro; Jose L Labandeira-Garcia
Journal:  Cell Death Dis       Date:  2017-09-07       Impact factor: 8.469
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.